Epidermolysis Bullosa Acquisita

  • Mei Chen
  • Dafna Hallel-Halevy
  • Celina Nadelman
  • David T. Woodley


Bullous Pemphigoid Epidermolysis Bullosa Porphyria Cutanea Tarda Lamina Densa Basement Membrane Zone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ackerman AB, Chongchitnant N, Sanchez J, Guo Y, Benin B, Reichel M, Randall MB (1997) Histologic diagnosis of inflammatory skin diseases: an algorithmic method based on pattern analysis. 2nd ed. Williams & Wilkins, BaltimoreGoogle Scholar
  2. Arpey CJ, Elewski BE, Moritz DK, Gammon WR (1991) Childhood epidermolysis bullosa acquisita: report of three cases and review of literature. J Am Acad Dermatol 24: 706–714PubMedGoogle Scholar
  3. Bauer JW, Schaeppi H, Metze D, Muss W, Pohla-Gubo G, Hametner R, Ruckhofer J, Grabner G, Hintner H (1999) Ocular involvement in IgA-epidermolysis bullosa acquisita. Br J Dermatol 141: 887–892CrossRefPubMedGoogle Scholar
  4. Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, Denoeux JP, Lorette G, Bonnetblanc JM, Prost C (1995) Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Arch Dermatol 131: 48–52Google Scholar
  5. Borradori L, Caldwell JB, Briggaman RA, Burr CE, Gammon WR, James WD, Yancey KB (1995) Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Arch Dermatol 131: 590–595CrossRefPubMedGoogle Scholar
  6. Briggaman RA, Wheeler CE Jr (1975) The epidermal-dermal junction. J Invest Dermatol 65: 71–84CrossRefPubMedGoogle Scholar
  7. Briggaman RA, Schechter NM, Fraki J, Lazarus GS (1980) Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J Exp Med 160: 1027–1042CrossRefGoogle Scholar
  8. Bruckner-Tuderman L, Nilssen O, Zimmermann DR, Dours-Zimmermann MT, Kalinke DU, Gedde-Dahl T Jr, Winberg JO (1995) Immunohistochemical and mutation analyzes demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain. J Cell Biol 131: 551–559CrossRefPubMedGoogle Scholar
  9. Burgeson RE (1993) Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J Invest Dermatol 101: 252–255CrossRefPubMedGoogle Scholar
  10. Callot-Mellot C, Bodemer C, Caux F, Bourgault-Villada I, Fraitag S, Goudie G, Heller M, de Prost Y, Prost C (1997) Epidermolysis bullosa aquisita in childhood. Arch of Dermatol 133: 1122–1126CrossRefGoogle Scholar
  11. Camara A, Becherel PA, Bussel A, Lagrange S, Chosidow O, Joly P, Piette JC, Frances C (1999) Resistant acquired bullous epidermolysis with severe ocular involvement: the success of extracorporeal photochemotherapy. Annal Dermatol Venereol 126: 612–615Google Scholar
  12. Chan LS, Fine JD, Briggaman RA, Woodley DT, Hammerberg C, Drugge RJ, Cooper KD (1993) Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease. J Invest Dermatol 101: 262–267PubMedGoogle Scholar
  13. Chan LS, Woodley DT (1996) Pemphigoid: Bullous and cicatricial. In Current Therapy in Allergy, Immunology and Rhematology, 5th ed, edited by LM Lichtenstein, AS Fauci Mosby, St Louis, p 93Google Scholar
  14. Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zones JJ, Black MM, Wojnarowask F, Stevens SR, Chen M, Failey JA, Miller SD, Gordon KB (1998) Epitope spreading: Lessons from autoimmune skin diseases. J Invest Dermatol 110: 103–109CrossRefPubMedGoogle Scholar
  15. Chen D, Welsh EA, Woodley DT, Wynn KC, Briggaman RA, Kim YH (1992): Passive transfer of autoantibodies of epidermolysis bullosa acquisita antibody into xenotransduced SCID mice with human graft. J Invest Dermatol 98: 589Google Scholar
  16. Chen M, Marinkovich MP, Veis A, O’Toole EA, Rao CN, Cai XY, Woodley DT (1997a) Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components: a potential role in epidermal-dermal adherence in human skin. J Biol Chem 272: 14516–14522CrossRefPubMedGoogle Scholar
  17. Chen M, Chan LS, Cai X, O’Toole EA, Sample JC, Woodley DT (1997b) Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol 108: 68–72CrossRefPubMedGoogle Scholar
  18. Chen M, O’Toole EA, Sanghavi J, Mahmud N, Kelleher D, and Woodley DT (1997c) Type VII collagen exists in human intestine and serves as an antigenic target in patients with inflammatory bowel disease. J Invest Dermatol 108: 542Google Scholar
  19. Chen M, Marinkovich MP, Jones JC, O’Toole E, Li YY, Woodley DT (1999) NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. J Invest Dermatol 112: 177–183CrossRefPubMedGoogle Scholar
  20. Chen M, Tahk SH, Costa FK, Kasahara N, Woodley DT (2000a) Recombinant expression of full-length type VII collagen alpha chain: structural and functional characterization and implication for gene therapy. J Invest Dermatol 114: 756Google Scholar
  21. Chen M, Wang J, Tahk SH and Woodley DT (2000b) Noncollagenous (NC2) domain of type VII collagen mediates the antiparallel-dimer formation of type VII collagen and constitutes a new antigenic epitope for EBA and BSLE autoantibodies. J Invest Dermatol 114: 766Google Scholar
  22. Choi GS, Lee ES, Kim SC, Lee S (1998) Epidermolysis bullosa aquisita localized to the face. J Dermatol 25: 19–22PubMedGoogle Scholar
  23. Cho HJ, Lee IJ, Kim SC (1998) Complement fixing abilities and IgG subclasses of autoantibodies in epidermolysis bullosa acquisita. Yonsei Medical Journal 39: 339–344PubMedGoogle Scholar
  24. Christiano AM, Greenspan DS, Lee S, and Uitto, J (1994) Cloning of human type VII collagen: complete primary sequence of the alpha 1(VII) chain and identification of intragenic polymorphisms. J Biol Chem 269: 20256–20262PubMedGoogle Scholar
  25. Connolly SM, Sander HM (1987) Treatment of epidermolysis bullosa acquisita with cyclosporin. J Am Acad Dermatol 16: 890Google Scholar
  26. Crow LL, Finkle JP, Gammon WR, Woodley DT (1988) Cleaning of epidermolysis bullosa acquisita on cyclosporin A. J Am Acad Dermatol 19: 937–942PubMedGoogle Scholar
  27. Cunningham BB, Kirchmann TT, Woodley DT (1996) Colchicine for epidermolysis bullosa (EBA). J Am Acad Dermatol 34: 781–784CrossRefPubMedGoogle Scholar
  28. Dahl MG (1979) Epidermolysis bullosa acquisita — a sign of cicatricial pemphigoid? Br J Dermatol 101: 475–483PubMedGoogle Scholar
  29. De Jong MCJM, Bruins S, Heeres K, Jonkman MF, Nieboer C, Boorsma DM, Pas HH, van der Meer JB (1996) Bullous pemphigoid and epidermolysis bullosa acquisita: Differentiation by fluorescence overlay antigen mapping. Arch Dermatol 132: 151–157CrossRefPubMedGoogle Scholar
  30. Domloge-Hultsch N, Anhalt GJ, Gammon WR, Lazarova Z, Briggaman R, Welch M, Jabs DA, Huff C, Yancey KB (1994) Antiepiligrin cicatricial pemphigoid: A subepithelial bullous disorder. Arch Dermatol 130: 1521–1529CrossRefPubMedGoogle Scholar
  31. Edwards S, Wakelin SH, Wojnarowska F, Marsden RA, Kirtschig G, Bhogal B, Black MM (1998) Bullous pemphigoid and epidermolysis bullosa acquisita: presentation, prognosis, and immunopathology in 11 children. Pediatr Dermatol 15: 184–190CrossRefPubMedGoogle Scholar
  32. Elliott GT (1895) Two cases of epidermolysis bullosa. J Cutan Genitourin Dis 13: 10Google Scholar
  33. Epstein JH, Tuffanelli DL, Epstein WL (1973) Cutaneous changes in the porphyrias. A microscopic study. Arch Dermatol 107: 689–698CrossRefPubMedGoogle Scholar
  34. Feliciani C, Di Muzio M, Mohammad Pour S, Allegretti T, Amerio P, Toto P, Coscione G, Proietto G, Amerio P (1998) ‘suction split’ as a routine method to differentiate epidermolysis bullosa acquisita from bullous pemphigoid. J Eur Acad Dermatol Venereol 10: 243–247CrossRefPubMedGoogle Scholar
  35. Fine JD, Tyring S, Gammon WR (1989) The presence of intra-lamina lucida blister formation in epidermolysis bullosa acquisita: Possible role of leukocytes. J Invest Dermatol 92: 27CrossRefPubMedGoogle Scholar
  36. Furue M, Iwata M, Yoon H-I, Kubota Y, Ohto H, Kawashima M, Tsuchida T, Oohara K, Tamaki K, Kukita A (1986) Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-BMZ antibody titer. J Am Acad Dermatol 14: 873–878PubMedGoogle Scholar
  37. Gammon WR, Briggaman RA, Wheeler CE Jr (1982) Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease. J Am Acad Dermatol 7: 382–387PubMedGoogle Scholar
  38. Gammon WR, Briggaman RA, Inman AO, Queen LL, Wheeler CE (1984a) Differentiating antilamina lucida and antisublamina densa anti-BMZ antibodies by indirect immunofluo-rescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol 82: 139–144Google Scholar
  39. Gammon WR, Briggaman RA, Woodley DT, Heald PW. Wheeler CE Jr (1984b) Epidermolysis bullosa acquisita — a pemphigoid like disease. J Am Acad Dermatol 11: 820–832PubMedGoogle Scholar
  40. Gammon WR, Woodley DT, Dole KC, Briggaman RA (1985) Evidence that basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigens. J Invest Dermatol 84: 472–476CrossRefPubMedGoogle Scholar
  41. Gammon WR (1988a) Epidermolysis bullosa acquisita. Semin Dermatol 7: 218–224PubMedGoogle Scholar
  42. Gammon WR, Heise ER, Burke WA, Fine JD, Woodley DT, Briggaman RA (1988b) Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: Evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol 91: 228–232CrossRefPubMedGoogle Scholar
  43. Gammon WR, Kowalewski C, Chorzelski TP, Kumar V, Briggaman RA, Beutner EH (1990) Direct immunofluorescence studies of sodium chloride-separated skin in the differential di-agnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol 22:664–670PubMedGoogle Scholar
  44. Gammon WR, Briggaman RA (1993) Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus: disease of autoimmunity to type VII collagen. Dermatol Clin 11: 535–547CrossRefPubMedGoogle Scholar
  45. Gammon WR, Murrell DF, Jenison MW, Padilla KM, Prisayanh PS, Jones DA, Briggaman RA, and Hunt SW III (1993) Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain. J Invest Dermatol 100: 618–622CrossRefPubMedGoogle Scholar
  46. Ghohestani RF, Nicolas JF, Roussele P, Claudy AL (1997) Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol 133: 1102–1107CrossRefPubMedGoogle Scholar
  47. Gordon KB, Chan LS, Woodley DT (1997) Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy. Br J Dermatol 136: 415–420CrossRefPubMedGoogle Scholar
  48. Harman KE, Whittam LR, Wakelin SH, Black MM (1998) Severe, refractory epidermolysis bullosa acquisita complicated by an oesophageal stricture responding to intravenous immune globulin. Br J Dermatol 139: 1126–1127CrossRefPubMedGoogle Scholar
  49. Hashimoto T, Ishiko A, Shimizu H, Tanaka T, Dodd HJ, Bhogal BS, Black MM, Nishikawa T (1996) A case of linear IgA bullous dermatosis with IgA antitype VII collagen autoantibodies. Br J Dermatol 134: 336–339CrossRefPubMedGoogle Scholar
  50. Hoang-Xuan T, Robin H, Heller M, Caux F, Prost C (1997) Epidermolysis bullosa acquisita diagnosed by direct immunoelectron microscopy of the conjunctiva. Ophthalmology 104: 1414–1420PubMedGoogle Scholar
  51. Jappe U, Zillikens D, Bonnekoh B, Gollnick H (2000) Epidermolysis bullosa acquisita with ultraviolet radiation sensitivity. Br J Dermatol 142: 517–520CrossRefPubMedGoogle Scholar
  52. Joly P, Ruto F, Thomine E, Delpech A, Balguerie X, Tron F, Lauret P (1993) Brunsting-Perry Cicatricial Bullous Pemphigoid: a clinical variant of localized acquired epidermolysis bullosa? J Am Acad Dermatol 28: 89–92PubMedGoogle Scholar
  53. Jones DA, Hunt SW III, Prisayanh PS, Briggaman RA, Gammon WR (1995) Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain. J Invest Dermatol 104: 231–235CrossRefPubMedGoogle Scholar
  54. Jonkman MF, Schuur J, Dijk F, Heeres K, de Jong MC, van der Meer JB, Yancey KB, Pas HH (2000) Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin α3. Arch Dermatol 136: 227–231CrossRefPubMedGoogle Scholar
  55. Kazama T, Yamamoto Y, Hashimoto T, Komai A, Ito M (1998) Application of confocal laser scanning microscopy to differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. Br J Dermatol 138: 593–601PubMedGoogle Scholar
  56. Koffer H, Wambacher-Gasser B, Topar G, Weinlich G, Schuler G, Hintner H, Romani N, Fritsch P (1997) Intravenous immunoglobulin treatment in therapy — resistant epidermolysis bullosa acquisita. J Am Acad Dermatol 36: 331–335PubMedGoogle Scholar
  57. Kurzhals G, Stolz W, Meurer M, Kunze J, Braun-Falco O, Krieg T (1991) Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid. Arch Dermatol 127: 391–395CrossRefPubMedGoogle Scholar
  58. Kushniruk W (1973) The immunopathology of epidermolysis bullosa acquisita. Can Med Assoc J 108: 1143–1146PubMedGoogle Scholar
  59. Lapiere JC, Woodley DT, Parente MG, Iwasaki T, Wynn KC, Christiano AM, Uitto J (1993) Epitope mapping of type VII collagen: identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 92: 1831–1839PubMedGoogle Scholar
  60. Lapiere JC, Chen JD, Iwasaki T, Hu L, Uitto J, Woodley DT (1994) Type VII collagen specifically binds fibronectin via a unique subdomain within the collagenous triple helix. J Invest Dermatol 103: 637–641CrossRefPubMedGoogle Scholar
  61. Lee CW (1998) Prevalences of subacute cutaneous lupus erythematosus and epidermolysis bullosa acquisita among Korean/oriental papulations. Dermatology 197: 187PubMedGoogle Scholar
  62. Lee CW (2000) Serum IgA autoantibodies in patients with epidermolysis bullosa acquisita: A high frequency of detection. Dermatology 200: 83–84CrossRefPubMedGoogle Scholar
  63. Lever WF, Schaumburg-Lever G (1990) Congenital disease (genodermatoses). In Histopathology of the skin, edited by WF Lever, G Schaumburg-Lever. Philadephia, Lippincott, p 78Google Scholar
  64. Lohi J, Leivo I, Tani T, Kiviluoto T, Kivilaakso E, Burgeson RE, Virtanen I (1996) Laminins, tenascin and type VII collagen in colorrectal mucosa. Histochem J 28: 431–440PubMedGoogle Scholar
  65. Mascaro JM Jr, Zillikens D, Giudice GJ, Caux F, Fleming MG, Katz HM, Diaz LA (2000) A subepidermal bullous eruption associated with IgG autoantibodies to a 200 kd dermal antigen: The first case report from the United States. J Am Acad Dermatol 242: 309–315CrossRefGoogle Scholar
  66. Megahed M, Scharfetter-Kochanek K (1994) Epidermolysis bullosa acquisita-successful treatment with colchicine. Arch Dermatol Res 286: 35–46CrossRefPubMedGoogle Scholar
  67. Miller JK, Stricklin GP, Fine JD, King LE, Arzubiaga MC, Ellis DL (1995) Remission of svere epidermolysis bullosa acquisita induced by extracoporeal photochemotherapy. Br J Dermatol 133: 467–471PubMedGoogle Scholar
  68. Nieboer C, Boorsma DM, Woerdeman MJ, Kalsbeek GL (1980) Epidermolysis bullosa acquisita: immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients. Br J Dermatol 102: 383–392PubMedGoogle Scholar
  69. Paller AS, Queen LL, Woodley DT, Lane AT, Gammon WR, Briggaman RA (1986) Organ specific, phylogenic and ontogenetic distribution of the epidermolysis bullosa acquisita antigen. J Invest Dermatol 86: 376–379PubMedGoogle Scholar
  70. Park SB, Cho KH, Youn JL, Hwang DH, Kim SC, Chung JH (1997) Epidermolysis bullosa aquisita in childhood — a case mimicking chronic bullous dermatosis of childhood. Clin Exp Dermatol 22: 220–222CrossRefPubMedGoogle Scholar
  71. Ray TL, Levine JB, Weiss W, Ward PA (1982) Epidermolysis bullosa acquisita and inflammatory bowel disease. J Am Acad Dermatol 6: 242–252PubMedGoogle Scholar
  72. Richter BJ, McNutt NS (1979) The spectrum of epidermolysis bullosa acquisita. Arch Dermatol 115: 1325–1328CrossRefPubMedGoogle Scholar
  73. Roenigk HH, Ryan JG, Bergfeld WF (1971) Epidermolysis bullosa acquisita: Report of three cases and review of all published cases. Arch Dermatol 103: 1–10CrossRefPubMedGoogle Scholar
  74. Rook AH, Jegasothy BV, Heald P, Nahass GT, Ditre C, Witmer WK, Lazarus GS, Edelson RL (1990) Extracoporeal photochemotherapy for drug-resistant pemphigus vulgaris. Ann Intern Med 112: 303–305PubMedGoogle Scholar
  75. Rusenko KW, Gammon WR, and Briggaman RA (1989) Type VII collagen is the antigen recognized by IgA anti-sub lamina densa autoantibodies. J Invest Dermatol 92: 510 AbstractGoogle Scholar
  76. Sakai LY, Keene DR, Morris NP, Burgeson RE (1986) Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol 103: 1577–1586CrossRefPubMedGoogle Scholar
  77. Schattenkirchner S, Eming S, Hunzelmann N, Krieg T, Smola H (1999) Treatment of epidermolysis bullosa acquisita with mycophenolate mofetil and autologous keratinocyte grafting. Br J Dermatol 141: 932–933CrossRefGoogle Scholar
  78. Schaumburg-Lever G, Rule A, Schmidt-Ullrich B, Lever WF (1975) Ultrastructural localization of in vivo bound immunoglobulins in bullous pemphigoid — A prelimnary report. J Invest Dermatol 64: 47–49CrossRefPubMedGoogle Scholar
  79. Stewart MI, Woodley DT, Briggaman RA (1991) Acquired epidermolysis bullosa and associated symptomatic esophageal webs. Arch Dermatol 127: 373–377CrossRefPubMedGoogle Scholar
  80. Tanaka H, Ishida-Yamamoto A, Hashimoto T (1997) A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen. Lab Invest 77: 623–632PubMedGoogle Scholar
  81. Taniuchi K, Inaoki M, Nishimura Y, Mori T, Takehara K (1997) Nonscarring inflammatory epidermolysis bullosa acquisita with esophageal involvement and linear IgG deposits. J Am Acad Dermatol 36: 320–322PubMedGoogle Scholar
  82. Tokuda Y, Amagai M, Yaoita H, Kawachi S, Ito T, Matsuyama I, Tsuchiya S, Saida T (1998) A case of inflammatory variant of epidermolysis bullosa acquisita: Chronic bullous dermatosis associated with non scarring mucosal blisters and circulating IgG anti-type-VII-collagen antibody. Dermatology 197: 58–61CrossRefPubMedGoogle Scholar
  83. Uitto J, Christiano AM (1994) Molecular basis for the dystrophic forms of epidermolysis bullosa: mutations in the type VII collagen gene. Arch Dermatol Res 287: 16–22CrossRefPubMedGoogle Scholar
  84. Vodegel RM, Kiss M, De Jong MCJM, Pas HH, Altmayer A, Molnar K, Husz S, Van Der Meer JB, Jonkman MF (1998) The use of skin substrate deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease. Eur J Dermatol 8: 83–85PubMedGoogle Scholar
  85. Wieme N, Lambert J, Moerman M, Geerts ML, Temmerman L, Naeyaert JM (1999) Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid. Dermatology 198: 310–313CrossRefPubMedGoogle Scholar
  86. Woodley DT, Sauder D, Talley MJ, Silver M, Grotendorst G, Qwarnstrom E (1983) Localization of basement membrane components after DEJ separation. J Invest Dermatol 81: 149–153CrossRefPubMedGoogle Scholar
  87. Woodley DT, Briggaman RA, O’Keefe EJ, Inman AO, Queen LL, Gammon WR (1984) Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 310: 1007–1015PubMedGoogle Scholar
  88. Woodley DT, O’Keefe EJ, Reese MJ, Mechanic GL, Briggaman RA, Gammon WR (1986) Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains. J Invest Dermatol 86: 668–672CrossRefPubMedGoogle Scholar
  89. Woodley DT (1988) Epidermolysis bullosa acquisita. Prog Dermatol 22: 1Google Scholar
  90. Woodley DT, Burgeson RE, Lunstrum G, Bruckner-Tuderman L, Reese MJ, Briggaman RA (1988) The epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 81: 683–687PubMedGoogle Scholar
  91. Woodley DT, Gammon WR, Briggaman RA (1998) Epidermolysis bullosa acquisita. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors. Dermatology in general medicine. 4th ed. Vols. I–II. McGraw-Hill, New York, 702–709Google Scholar
  92. Yancey KB. Cicatricial pemphigoid. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (1998) Dermatology in general medicine. 4th ed. Vols. I–II. McGraw-Hill, New York, Inc., pp 674–679Google Scholar
  93. Yaoita H, Briggaman A, Lawley TJ, Provost TT, Katz SI (1981) Epidermolysis bullosa acquisita: Ultrastructural and immunological studies. J Invest Dermatol 76: 288–292CrossRefPubMedGoogle Scholar
  94. Zillikens D, Wever S, Roth A, Hashimoto T, Brocker EB (1995) Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 131: 957–958CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2005

Authors and Affiliations

  • Mei Chen
  • Dafna Hallel-Halevy
  • Celina Nadelman
  • David T. Woodley

There are no affiliations available

Personalised recommendations